A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Clinical trial NCT04074330 · TERMINATED

Trial details

NCT number: NCT04074330
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2019-10-15
Primary completion: 2023-04-26
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.